ArticleFrontiers in pharmacology2022

Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects.

James Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.